Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules with potential antipsychotic or anxiolytic activity. The presence of bromo and fluoro substituents allows for selective functionalization through cross-coupling reactions, making it valuable in medicinal chemistry for building complex heterocyclic systems. It is also employed in research settings to explore structure-activity relationships in benzoxazine-based drug candidates.